Treatment with lipoxin A4 improves influenza A infection outcome, induces macrophage reprogramming, anti-inflammatory and pro-resolutive responses

Related articles

1. The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19

   This article has 10 authors:

   1. Yvette Kazungu
   2. Shrilakshmi Hegde
   3. Parul Sharma
   4. Amy Marriott
   5. Andrew Steven
   6. Jesus Reine
   7. Jessica Dagley
   8. Matthias Mack
   9. James Stewart
   10. Joseph D Turner

2. Type I Interferon production in myeloid cells is regulated by factors independent of Ptpn22

   This article has 5 authors:

   1. Jenna R. Barnes
   2. Anam Fatima Shaikh
   3. Alec M. Bevis
   4. Tammy R. Cockerham
   5. Robin C. Orozco

3. Role of IL10 signaling in the circadian control of host response to Influenza infection

   This article has 14 authors:

   1. Kaitlyn Forrest
   2. Martina Towers
   3. Oindrila Paul
   4. Hyeonbin Cho
   5. Mahendra V. Padmini
   6. Amruta Naik
   7. Haeum Karrisa Lim
   8. Yasmine Issah
   9. Hitesh Deshmukh
   10. Michael C. Abt
   11. Kristin Hudock
   12. Gregory R. Grant
   13. Thomas G. Brooks
   14. Shaon Sengupta